Substance Name: Balstilimab [USAN]
RN: 2148321-77-9
UNII: 1Q2QT5M7EO
Molecular Formula
- C6336-H9764-N1704-O1990-S44 (non glycosylated)
Classification Code
- Treatment of Cancer
* denotes mobile formatted website
Links to Resources
NLM Resources (File Locators)
Other Resources (Internet Locators)
Names and Synonyms
Name of Substance
- Balstilimab
- Balstilimab [USAN]
Synonyms
- A fully human IGG4 monoclonal antagonist antibody directed against programme D cell death protein 1 (pd-1) with potential immune checkpoint inhibitory and antineoplastic activities
- AGEN-2034
- AGEN2034
- anti-Pd1 monoclonal antibody AGEN2034
- Balstilimab
- Balstilimab [INN]
- Immunoglobulin G4, anti-(human programmed cell death protein 1) (human monoclonal AGEN2034 gamma4-chain), disulfide with human monoclonal AGEN2034 kappa-chain, dimer
- UNII-1Q2QT5M7EO
- WHO 10993
Registry Numbers
CAS Registry Number
- 2148321-77-9
FDA UNII
- 1Q2QT5M7EO
System Generated Number
- 2148321779